GKIM
AGIO icon

GW&K Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

GW&K Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.8M Sell
1,206,615
-8,286
-0.7% -$251K 0.35% 103
2026
Q1 		$41.1M Buy
1,214,901
+7,600
+0.6% +$215K 0.36% 100
2025
Q4 		$32.9M Buy
1,207,301
+354,359
+42% +$12.4M 0.28% 138
2025
Q3 		$34.2M Sell
852,942
-15,676
-2% -$590K 0.3% 131
2025
Q2 		$28.9M Buy
868,618
+51,092
+6% +$1.55M 0.26% 154
2025
Q1 		$24M Buy
817,526
+134,063
+20% +$4.45M 0.22% 176
2024
Q4 		$22.5M Buy
683,463
+52,517
+8% +$2.47M 0.19% 192
2024
Q3 		$28M Buy
630,946
+35,880
+6% +$1.63M 0.24% 170
2024
Q2 		$25.7M Sell
595,066
-54,319
-8% -$1.96M 0.23% 169
2024
Q1 		$19M Buy
+649,385
New +$17.4M 0.17% 200

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

GW&K Investment Management's AGIO Position: Q2 2026 in Review

GW&K Investment Management reduced its Agios Pharmaceuticals (AGIO) stake by 0.68% in Q2 2026, selling an estimated $251K and leaving 1,206,615 shares worth $44.8M. The position accounts for 0.35% of the portfolio, ranked #103.

GW&K Investment Management first reported a position in AGIO in Q1 2024 and has held it in 10 quarters since. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • GW&K Investment Management held 1,206,615 shares of Agios Pharmaceuticals worth $44.8M as of Q2 2026.
  • GW&K Investment Management sold 8,286 Agios Pharmaceuticals shares in Q2 2026, an estimated $251K.
  • Agios Pharmaceuticals made up 0.35% of GW&K Investment Management's portfolio in Q2 2026, its #103 holding.
  • GW&K Investment Management first reported a position in Agios Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.